Bortezomib has anti-proliferative and apoptotic effects against quiescent CML stem cells and cells expressing the T3151 mutation

N.B. Heaney, F. Pellicano, Lisa Crawford, S.M.A. Kazmi, Alexandra Irvine, T.L. Holyoake

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)58-58
Number of pages1
JournalBritish Journal of Haematology
Publication statusPublished - Apr 2008

Cite this